About: Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$7.55 (-4.19%)
AVR ASX Anteris Technologies Global Corp
Anteris Technologies Global Corp share price
AVR price activity
Last Price
$7.550
Change (24hr)
-0.33 AUD (4.19%)
Volume
6.50K
Volume (4w avg)
-
Open
$7.81
Day Range
$7.55 - $7.81
Previous Close
$7.88
Last Trade
20 Nov, 3:12 am GMT+0
Delayed
20 Nov, 3:12 am GMT+0
AVR price performance
Delayed
20 Nov, 3:12 am GMT+0
AVR details
AVR Market Signals